Abstract
In recent years, nanocarriers have played increasingly significant roles in cancer therapy. Among various nanoplatforms, mesoporous silica nanoparticles (MSNs) have been given serious attention due to their good colloidal stablity, tunable pore sizes, extensive drug loading capacity and easily modified surface. In this review, functionalized MSNs are introduced as an efficient nanocarrier for cancer treatment. First, MSN preparation strategies are generally introduced. Next, passive and active tumor targeting methods for the functionalization of MSNs are reviewed. Then, several types of stimuli-responsive strategies for on-demand drug release, a wide variety of designs integrating with magnetic resonance imaging agents, optical imaging agents, and positron emission tomography imaging agents, etc. for theranostic purpose are summarized. A discussion relating to the future perspectives of MSNs for clinical translocation is also included in this review.
Keywords: Mesoporous silica nanoparticles, functionalization, tumor targeting, stimuli-responsive, drug delivery, theranostics.
Current Pharmaceutical Design
Title:Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics
Volume: 23 Issue: 23
Author(s): Wenjia Zhang, Mengrui Liu, Anchang Liu*Guangxi Zhai*
Affiliation:
- Department of Pharmacy, Qilu Hospital of Shandong University, P.O. Box: 250012, Jinan,China
- Department of Pharmaceutics, College of Pharmacy, Shandong University, P.O Box: 250012, Jinan,China
Keywords: Mesoporous silica nanoparticles, functionalization, tumor targeting, stimuli-responsive, drug delivery, theranostics.
Abstract: In recent years, nanocarriers have played increasingly significant roles in cancer therapy. Among various nanoplatforms, mesoporous silica nanoparticles (MSNs) have been given serious attention due to their good colloidal stablity, tunable pore sizes, extensive drug loading capacity and easily modified surface. In this review, functionalized MSNs are introduced as an efficient nanocarrier for cancer treatment. First, MSN preparation strategies are generally introduced. Next, passive and active tumor targeting methods for the functionalization of MSNs are reviewed. Then, several types of stimuli-responsive strategies for on-demand drug release, a wide variety of designs integrating with magnetic resonance imaging agents, optical imaging agents, and positron emission tomography imaging agents, etc. for theranostic purpose are summarized. A discussion relating to the future perspectives of MSNs for clinical translocation is also included in this review.
Export Options
About this article
Cite this article as:
Zhang Wenjia, Liu Mengrui, Liu Anchang*, Zhai Guangxi*, Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics, Current Pharmaceutical Design 2017; 23 (23) . https://dx.doi.org/10.2174/1381612822666161025153619
DOI https://dx.doi.org/10.2174/1381612822666161025153619 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Prediction of Carcinogenicity from Molecular Structure
Current Computer-Aided Drug Design Editorial [Hot Topic: Bacterial Vectors for Gene & Cell Therapy (Guest Editors: Mark Tangney & Cormac G.M. Gahan)]
Current Gene Therapy Chemoresistance of Cancer Cells: Oncogenic Mutation of the p53 Tumor Suppressor Gene
Current Signal Transduction Therapy PEDF as an Emerging Therapeutic Candidate for Osteosarcoma
Current Cancer Drug Targets Expression and Functions of Heat Shock Proteins in the Normal and Pathological Mammalian Eye
Current Molecular Medicine Understanding XPO1 Target Networks Using Systems Biology and Mathematical Modeling
Current Pharmaceutical Design Oncogenic Signalling Networks and Polypharmacology as Paradigms to Cope with Cancer Heterogeneity
Current Proteomics Cytoplasmic CXCR4 High-Expression Exhibits Distinct Poor Clinicopathological Characteristics and Predicts Poor Prognosis in Triple-Negative Breast Cancer
Current Molecular Medicine Thrombotic Microangiopathies: Towards a Pathophysiology-Based Classification
Cardiovascular & Hematological Disorders-Drug Targets Recent Developments Towards the Synthesis of Varitriol: An Antitumour Agent from Marine Derived Fungus Emericella Variecolor
Current Organic Synthesis Signal Transduction and Photodynamic Therapy
Current Signal Transduction Therapy Using Nutrigenomics to Evaluate Apoptosis as a Preemptive Target in Cancer Prevention
Current Cancer Drug Targets Lipid Microparticles for Oral Bioavailability Enhancement
Recent Patents on Nanomedicine Combination of Hypoxia and RNA-Interference Targeting VEGF Induces Apoptosis in Hepatoma Cells Via Autocrine Mechanisms
Current Pharmaceutical Biotechnology Aging, Mitochondria and Male Reproductive Function
Current Aging Science Management of Peyronie's Disease after Collagenase (Xiaflex:<sup>®</sup>)
Current Drug Targets Experimental Models for Evaluation of Nanoparticles in Cancer Therapy
Mini-Reviews in Medicinal Chemistry CFTR Gene Transfer to Lung Epithelium - On the Trail of a Target Cell
Current Gene Therapy Molecular Targets of Tannic Acid in Alzheimer's Disease
Current Alzheimer Research Editorial: Primary Systemic Therapy for Breast Cancer
Reviews on Recent Clinical Trials